DAFTAR PUSTAKA
Abboth, 2006. Glucose. Clinical Chemistry. Architec-Aeroseth. Abboth Diagnostic. p 1-8
Abboth, 2006. Cholesterol. Clinical Chemistry. Architec-Aeroseth. Abboth Diagnostic. p 1-12
Abboth, 2007. Triglyseride. Clinical Chemistry. Architec-Aeroseth. Abboth Diagnostic. p 1-9
Abboth, 2008. UHDL. Clinical Chemistry. Architec-Aeroseth. Abboth Diagnostic. p 1-9
Adekune, A.E. Akande, A.O. Adekunle, A.O. 2014. Metabolic Syndrome:Prevalence and Association with Electrocardiographic
Abnormalities in Nigerian Hypertensive Patients.Vol : 12(8) : 447 – 442.
Anwar, T.B. 2004. Dislipidemia sebagai factor resiko Penyakit Jantung Koroner. Fakultas Kedokteran . e-Universitas Sumatera Utara. p.2. Atkinson, R. 2004. Etiology of obesity : In The management of eating disorder
and obesity. Goldstein, J.D.ed. 2nd ed, New Jersey. Human Press Inc. pp.105.
Ascaso, J.F. Pardo, S. Real, J.T. et.al. 2003. Diagnosis insulin resistance by simple quantitative methods in subjects with normal glucose
Aquilante, C.L. and Griend J.P. V.2012. Metabolic syndrome. Pharmacotherapy Self-Assessment Program. 6th Ed. 109 – 115.
Balai Penelitian dan Pengembangan Kesehatan , 2007. Depkes RI. Pedoman Pengukuran dan Pemeriksaan. Riset Kesehatan Dasar.
Bakker, S.J. Gans, R. Maaten, J.C. 2001.The Potential Role of Adenosine in The Pathophysiology of The Insulin Resistance Syndrome. Atherosclerosis 2001. 156: 283 – 290.
Bosomworth, N.J.2013. Approach to identifying and managing atherogenic dyslipidemia. Canadian Family Physician. Vol 59: 1169 -1180.
Brunzel, J.D. 2009. Genetic Dyslipidemia In : Clinical Lipidology .
Christie,M.ed. Saunders Elsevier. 1st ed. pp 71-80.
Byrne, C.D. 2005. The Global Burden of the Metabolic Syndrome and its Consequencea for Diabetes and Cardiovascular. Dalam : Metabolic Syndrome. England. Byrne, C.D. and Wild, S.W.ed. John Wiley & Sons Ltd. pp. 1.
Byun, A.R. Wha S.L. Lee, H.S. Shim, K.W. 2015. What is the most appropriate lipid profile ratio predictor for insulin resistance in each
sex? A cross sectional study in Korean populations (the fifth korea
Cerelio, A .2005. Oxidate stress, insulin resistance and cardiovascular disease : In Metabolic Syndrome. Byrne, C.D. England : John Wiley & Sons Ltd, pp. 191-190.
Chaves, A.G. Mendia, L.E.S. Argueta, S.E. 2011. Elevated triglycerides/HDL cholesterol associated with insulin resistance. Cirugia y Cirujanos . 79 :115 – 119.
Cornier, M.A. Dabelea , D. Hernandez T.L. et.al. 2008. The metabolic Syndrome : Endocrine Review. 29(7) :777 – 822.
Chu, M.A.2011. HOMA-IR and Its Association with Metabolic Risk Factors among Korean Adolescent. Korean J Gastroenterolog Nutric.14(4): 376 -384
Davis, P.G. 2006. Lipid and lipoprotein metabolism. In : Lipid metabolism and health. Moffat, R.J., Stamford, B. ed. United States of Taylor : Taylor & Francis Group. p. 47-50.
Du, T. Yuan,G. Zhang, M. et.al.2014. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as
risk markers of insulin resistance. Cardiovascular Diabetology. :134. p1-10.
Ezra, V.B.(2006) Metabolic Syndrome In : Lipid metabolism and health.
Moffat, R.J., Stamford, B. ed. United States of Taylor : Taylor & Francis Group. p. 47-50.
Gerich, J.E. Dodis, R. 2007. Glycemic control and the metabolic syndrome : In Metabolic syndrome and cardiovascular, epidemiology, assesement and management. Krentz, A.J.ed. United State of America. Informa health care USA Inc, pp.145-155.
Giannini, C. Santoro, N. Caprio, S.et.al. The triglyserida to HDL cholesterol ratio. Diabetes Care, volume 34 :1869 – 1874.
Gurung, A. Shivsekhar, M. 2013. Study of insulin resistanse and lipid profile in obese adults : International Journal of Science Innovation and Discoveries. 3 : 362-366.
Halim ,S.L. Iskandar, I. Edward, H. 2011. Kimia Klinik, Fakultas Kedokteran. UKRIDA. Jakarta. p.10.
Hancox, R.J.2011. Corelation between measure of insulin resistance in fasting and non fasting blood. Diabetology and Metabolic Syndrome. 3:23.
Haris , S. dan Tambunan, T.2009. Hipertensi Pada Sindroma Metabolik. Sari Pediatri. 11(4) : 257-264.
He, J.2014. The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance Chinese Non obese Women. International Journal of Endocrinology. P. 1-7.
Hermanto, T.J., Sony, W. Banjarnahor, D.P.P. 2012. Korelasi antara HOMA-IR Ibu Diabetes Mellitus Gestasional Trimester Tiga dengan Luaran Maternal dan Neonatal. Majalah Obstetri & Ginekologi. 20(3) : 122-126
Huguette,Y.M.2010.Prevalenceof insulin resistance in obese Cameroonian Women. Journal of Diabetes and Endocrinology. vol. 1. pp. 19–26. Imanuel, S. 2013. Patogenesis dan diagnosis laboratorik pradiabetik.
Departemen Patologi Klinik Fakultas Kedokteran Universitas Indonesia. Pendidikan Kedokteran Berkelanjutan Patologi Klinik. pp.15.
Jafar, N. 2012. Sindroma Metabolik dan Epidemiologi : Media Gizi Masyarakat Indonesia.1(2):71-78.
Jung, C.H 2010. The Relationship of Adiponectin/Leptin Ratio with Homeostasis Model Assessment Insulin Resistance Index and Metabolic Syndrome in Apparently Healthy Korean Male Adults. Korean Diabetes J 2010;34:237-243.
Kumar, A. Singh, V.2010. Atherogenic dyslipidemia and diabetes mellitus:
what’s new in the management arena?. Vascular Health and Risk
Management . 6 :665-669
Kaur. J. 2014. A Comphrehensive Review on Metabolic Syndrome : Review Article. Cardiology Research and Practice. Hindawi Publishing Corporation. 31.pp.21.
Kawamoto, R. Tabara, Y. Kohara, K. et.al. 2011. Relation between lipid profile and metabolic syndrome, insulin resistance and serum high
molecular adiponectin in Japanese community-dwelling adults : Lipid in Health and Disease. 10:79
Kawamoto, R. Kohara, K. Kusunoki,T., et.al. 2012. Alanine aminotransferase/aspartate aminotransferase ratio is the best
surrogate makrker insulin resistance in non obese Japanese adults.
Cardiovascular Diabetology. 11:117.
Kimm, H. Lee, S.W. Lee H.S. Shim, K.W. 2010. Association Between Lipid Measure and Metabolic Syndrome, Insulin Resistance and
Adiponectin. Circulation Journal. Vol.74. p 931-937.
Ku, B.J. 2009. Serum ferritin is inversely correlated with serum adiponectin level: Population-based cross-sectional study. Disease Markers .Vol 27. 303–310
Kurzmarski, R.J. Flegal, K.M. 2000. Criteria for definition of overweight in transition : background and recommendation for the United States. The american Journal of clinical nutrition. 72 : 1074 – 81.
Lee, S.R. Cha, M.J. Kang, D.Y.et. al. 2011. Increased prevalence of metabolic syndrome among hypertension population. International Journal of Cardiology. Volume 166. Issue 3. p 633 – 639.
Lee, U.P. 2007. Insulin, lipid profiles and measures of fatness in Taiwanese women in relation to duration of residence in Australia. Asia Pac J Clin Nutr :16 (2):254-261
Leslie, B. 2005. Metabolic Syndrome. Historical Perspective. The American Journal of Medical Science. 330 (6)p. 264 – 268.
Lwanga, S.K. and Lemeshow, S. 2004Sample size determination in health studies. World Health Organization. Geneva.
Madsen, C.R. 2012. Tissue Spesific Insulin Signaling, Metabolic Syndrome and CVD. Thromb Vasc Biol. 32(9): 2052-2059
Marjani,A. 2011. Waist Circumference, Body Mass Index, Hip Circumference and Waist-To-Hip Ratioin type 2 diabetes patients in Gorgan, Iran. Journal of Clinical and Diagnostic Research. Vol-5(2):201-205
Mashabi, Y. 2013. Penilaian ratio Apo B/Apo A pada subjek sindroma metabolik dan obesitas, Tesis. Program Magister Klinik – Spesialis Patologi Klinik. Fakultas Kedokteran Universitas Sumatera Utara – Rumah Sakit Umum Pusat Haji Adam Malik. pp.25
McLaughlin, T. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. vol. 139. no. 10, pp. 802–809.
Merentek, E., 2006, Resistensi Insulin Pada Diabetes Mellitus Tipe 2, Cermin Dunia Kedokteran, No 150, 39-41, Poliklinik Endrokrin Metabolik, Bagian Penyakit Dalam Rumah Sakit Umum Gowa, Makasar.
Meshkani, R. Adeli, K. 2009. Mechanism linking the metabolic syndrome and cardiovascular disease : role of hepatic insulin resistance. The journal of Tehran Univlersityl Hearth Center, pp. 77 – 83.
Mittal, S. 2008. The metabolic syndrome in clinical practice, Spinger –Verlag, London. pp.40.
Mohiuddin, S.M. 2013. The Association Between Serum Lipid Ratio and Insulin Resistance Among Subject with Impaired Glucose Tolerance in Pakistan. University of Oslo Institue of Health and Society. Departemen of Community Medicine,Pakistan.Thesis.p.43.
Momin, A.A. Bankar, M.P. Bhoite, G.M. 2014. Determination of HOMA IR cut off value, and efficiency of lipids and lipoprotein ratios as discriminator
of insulin resistance in type 2 Diabetes Mellitus patients. Journal Of Pharmacy. Vol 4. Issue 6. Pp09-14.
Mostafa, S.A. 2012. The Association of the Triglyceride-to-HDL Cholesterol Ratio with Insulin Resistance in White Europe and South Asian Men and Women. PlosOne.7(12).P.1-7
Olivia, A.2011. Examining the Association Between Body Mass Index and Weight Related Quality of Life in Black and White Women. Quality of Life Journal. Volume 7. Issue 3. Pp 309 – 322.
Olson, K. 2012. The Triglyceride to HDL Ratio And its Relatonship to Insulin Resitance in Pre –and Postpubertal Children : Observation from the
Wasau SCHOOL Project. Hindawi Publishing Corporation Cholesterol.p1-4.
Pitocco, D., Tesauro, M., Allesandro, R., et.al. 2013. Oxidative stress in diabetes : implication for valscular other implication. International Journal of Molecular Science. 14 : 21525 – 21550.
Polyana, R.S. 2015. Correlation of Insulin Resistance with Anthropometric Measures and Blood Pressure in Adolescents. Arq Bras Cardiol. P .1-8 Pownall, H.J. and Gotto, A.M. 2009. Human Plasma Lipoprotein : In Clinical
lipidology a companion to Braunwald’s hearth disease. Ballantyne,
C.M.ed. Philadelphia, 1st ed. Elsiver. pp. 1-5.
Radikova, Z.2003. Assessment of Insulin Sensitivity/Resistance in Epidemilogical. Endocrine Regulation. 37:189-194.
Ray, S. Talukadar, A. Sonthalia , N. et.al. 2015 Serum lipoprotein ratio as marker of insulin resistance : A study among non-diabetic acute
coronoray syndrome patient with impaired fasting glucose. Indian Journal Medical Research. 141 : 62-67.
Redon, J. Cifkova ,R.Laurent ,S. et.al. The metabolic syndrome in hypertension: European society of hypertension position statement. Journal of Hypertension 2008, 26:1891–1900
Riset Kesehatan Dasar 2013. Badan penelitian dan pengembangan kesehatan. Kementerian Kesehatan Republik Indonesia. p.16.
Sharma, J. Khare, S. Shrivastavia S.,Kaira, S. 2011. Etiology of obesity : what a family practitioner needs to know. Research of diabetes and endocrinologly. webmed central . pp.1-9
Shentil. 2012. Association between liver insulin resistance and cardiovascular risk factors.The Association for the Publication of the Journal of Internal Medicine 403. Journal of Internal Medicine. 272: 402–408. Shinsha, S. and Akhter, Q.S. 2015. Correlation Study of Insulin Resistance
and Essential Hypertension among Bangladeshi Male Volunteers. Journal of Young Pharmacists .7(3) .p.201-205
Shood, R.2006. The Endocryne System in Textbook of Medical Laboratory. Medical Publisher. P.585
Silalahi, T. 2013. Perbedaan kadar hs-CRP pada subjek obesitas sindrom metabolik dan non sindrom metabolik. Tesis,. Program Magister Klinik – Spesialis Patologi Klinik, Fakultas Kedokteran Universitas Sumatera Utara – Rumah Sakit Umum Pusat Haji Adam Malik. pp.31. Simanjuntak, Z. 2013. Hubungan serum ferritin dengan resistensi insulin yang
dihubungkan dengan HOMA-IR pada penderita sindroma metabolik.
Tesis. Program Magister Klinik – Spesialis Patologi Klinik, Fakultas Kedokteran Universitas Sumatera Utara – Rumah Sakit Umum Pusat Haji Adam Malik.pp. 17.
Sumner, A.E. 2005. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans, Archives of Internal Medicine, vol. 165, no. 12, pp. 1395–1400.
Soegondo, S. 2001. Atherogenic dyslipidemia and the metabolic syndrome clinical practice. Arta medical indonesia – Indonesia Jurnal Internasional Medikal. 37 : 177 – 183.
Soh, J. Josekutty, J. Hussain, M.M. 2011. Lipid and dyslipoproteinemia : In Henry’s clinical diagnosis and management by laboratory methods.
Mc.Pherson, R.A., & Pincus, M.R.ed. Philadelphia, 22nd ed, Elsevier. p.226.
Sulistyoningrum. 2010. Tinjauan molekuler dan aspek klinis resistensi insulin.
Fakultas Kedokteran dan Ilmu kesehatan. Universitas Jenderal Soedirman. Mandala of health journal . 2 :131-138
Tabata, S. 2009. Waist circumference and insulin resistance : a cross-sectional study of Japanese men. BMC Endocrine Disorder. Vol 10.1186/1472-6823-9-1.
Umboh, A. 2007. Hubungan Antara Resistensi Insulin dan Tekanan Darah Pada Anak Obese. Sari Pediatri. Vol 8. No 4. P 289 – 293.
Journal of Internal Medicine 403. Journal of Internal Medicine. 272: 402–408.
Vigil,L and Goday. A. 2011. Metabolic syndrome and insulin resistance are associated with Chronic Kidney Disease in Non Diabetic with
Abdominal Obesity. International journal of clinical medicine. 2011. 367 – 377.
Wallace, T.M. Levy J.C.. and Matthew D.R.2004. Use and Abuse of HOMA Modelling. Diabetes Care. 27: 1487 – 1495.
Waist circumference and waist hip ratio. 2008. Report of a WHO expert consultation. Geneva, pp.8.
Wilcox, G. 2005. Insulin and Insulin Resistance. Clinical Biochemistry Review.; 26(2): 19 – 39.
Yoon, H. and Jeon, J.D. 2016. Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults. J.Clin. Biochem. Nutr.p 1 – 6.
